Company Acer Therapeutics Inc.
Equities
ACER
US00444P1084
Biotechnology & Medical Research
Business Summary
Number of employees: 33
Managers
Managers | Title | Age | Since |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 11-16 |
Tanya Hayden
COO | Chief Operating Officer | 44 | 21-05-31 |
John M. Klopp
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Jim DeNike
IRC | Investor Relations Contact | - | - |
Bernie Paul
HRO | Human Resources Officer | 65 | 19-04-30 |
Renee Carroll
LAW | General Counsel | - | 19-12-31 |
Jason Kneeland
AUD | Comptroller/Controller/Auditor | - | 17-10-31 |
Kim Tharaldsen
SAM | Sales & Marketing | - | 18-02-04 |
Corporate Officer/Principal | 57 | 13-11-30 | |
Donald Joseph
LAW | General Counsel | 70 | 18-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 11-16 |
Joshua Schafer
BRD | Director/Board Member | 53 | 11-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,463,726 | 24,463,726 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |